Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Smoking 1 Pulmonary Disease, Chronic Obstructive 1 Neoplasms 1 Melanoma 1 Diabetes Mellitus 1 Dementia 1 Cardiovascular Diseases 1 Carcinoma, Hepatocellular 1 Breast Cancer Female 1 Atherosclerosis 1

Interventions

Sorafenib 9 gadolinium ethoxybenzyl DTPA 4 Hepatectomy 4 lenvatinib 3 entecavir 3 Sufentanil 3 Ribavirin 3 Propranolol 3 Lamivudine 3 sofosbuvir-velpatasvir drug combination 2 peginterferon alfa-2a 2 gadoterate meglumine 2 atezolizumab 2 Thrombectomy 2 Tenofovir 2 Sevoflurane 2 Radiofrequency Ablation 2 Laparoscopy 2 Esketamine 2 Chemoembolization, Therapeutic 2 Bevacizumab 2 xihuang 1 stronger neominophagen C 1 ledipasvir 1 huaier 1 halofantrine 1 gadoteridol 1 gadodiamide 1 gadobutrol 1 gadobenic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Carcinoma, Hepatocellular × Atorvastatin × Clear all

NCT03024684 2024-11-12

SHOT

Chiayi Christian Hospital

Phase 4 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡